Table 4. Comparison of demographics and relevant comorbidities between patients with normal IENFD on skin biopsy and patients with reduced IENFD on skin biopsy.
Normal IENFD (n = 61) | Abnormal IENFD (n = 19) | p-value | |
Age (years) | 32 ± 9 | 41 ± 13 | 0.001 |
Percent female | 90% | 84% | 0.44 |
%White | 87% | 95% | 0.058 |
Symptom duration (years) | 5 (4, 6) | 7 (3, 10) | 0.20 |
Comorbidities | |||
Autoimmune disease (celiac, Hashimoto’s, RA, Sjogren’s) | 16% | 37% | 0.10 |
Chiari | 5% | 2% | 0.42 |
Ehlers-Danlos/Jjint hypermobility | 31% | 11% | 0.13 |
Fibromyalgia | 34% | 16% | 0.16 |
Migraine | 61% | 53% | 0.60 |
Raynaud’s | 23% | 16% | 0.75 |